Paratek Pharmaceuticals, Inc.

PA · United States · Reporting entity ID 100000476817

Total reported 2019–2025

$19.0M

#334 of 2,960 reporting companies — 0% of all reported industry payments

$8.22M in general payments across 111,920 records, plus $10.8M in research funding across 1,026 records.

How it breaks down

General payments $8,216,303

Research funding $10,827,795

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.